Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1054)
  3. Book Section (64)
  4. Review (63)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2692)
  2. Department of Medicine (2692)
  3. Hematologic Malignancies, Division of (2692)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (653)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (442)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (39)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (275)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (291)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2692)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early treatment with epoetin alfa improves anemia, quality of life (QOL), and productivity in patients (Pts) with hematologic malignancies and mild anemia during chemotherapy (CT)
    Meeting Abstract

    Straus, D. J.; Testa, M.; Riggs, S. A.; Tulpule, A.; Sarokhan, B.
    Blood (2003)

    Fulltext@MSK | Save
  • Head to head comparison of Gallium-67 imaging and FDG PET in lymphoma patients
    Meeting Abstract

    Schoder, H.; Noy, A.; Gonen, M.; Young, K. S.; Larson, S. M.; Yeung, H. W.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • A heteroclitic peptide vaccine induces CD8(+) T-cell responses to CD20
    Meeting Abstract

    Palomba, M. L.; Guevara-Patiño, J. A.; Manukian, G.; Houghton, A. N.
    Blood (2003)

    Fulltext@MSK | Save
  • Promising activity of the proteasome inhibitor bortezomib (velcade) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma
    Meeting Abstract

    O'connor, O.; Wright, J.; Moskowitz, C. H.; Muzzy, J.; Macgregor-Cortelli, B.; Hamlin, P.; Straus, D.; Trehu, E.; Schenkein, D. P.; Zelenetz, A. D.
    Blood (2003)

    Fulltext@MSK | Save
  • Cytogenetic analysis of follicular lymphoma: Chromosome instability associated with t(14;18)(q32;q21) positive and negative subsets, histology and transformation
    Meeting Abstract

    Nanjangud, G.; Naresh, K.; Teruya-Feldstein, J.; Olshen, A. B.; Wilton, A. S.; Parsa, N. Z.; Rao, P. H.; Filippa, D. A.; Hegde, A.; Hedvat, C. V.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Risk-adpated high dose chemoradiotherapy and ASCT for patients with relapsed and primary refractory Hodgkin's disease: An intent to treat analysis
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Rice, R. D.; Rosenzweig, L.; Horwitz, S.; Noy, A.; O'connor, O.; Portlock, C. S.; Straus, D.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Follicular lymphoma grade 3 is not equivalent to follicular large cell lymphoma: Comparison of the WHO and IWF classification system
    Meeting Abstract

    Halaas, J. L.; Feldstein, J. T.; Zelenetz, A. D.
    Blood (2003)

    Fulltext@MSK | Save
  • The BEXXAR (R) therapeutic regimen (Tositumomab and iodine I 131 tositumomab) can be safely administered to patients over the age of 70
    Meeting Abstract

    Gregory, S. A.; Zelenetz, A. D.; Knox, S. J.; Vase, J. M.; Kaminski, M. S.
    Blood (2003)

    Fulltext@MSK | Save
  • Bexxar® (tositumomab and iodine I 131 tositumomab) is well tolerated and efficacious in heavily pretreated patients with non-Hodgkin's lymphoma (NHL) and mild thrombocytopenia
    Meeting Abstract

    Goldsmith, S. J.; Kostakoglu, L.; Wahl, R.; Alavi, A.; Divgi, C.; Hankins, J.; Zelenetz, A.; Kaminski, M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Utilization of rituximab therapy in patients (pts) with newly diagnosed follicular (FL) and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in the United States: An analysis from the national comprehensive cancer network (NCCN) NHL outcomes project
    Meeting Abstract

    Friedberg, J. W.; Lepisto, E.; Rodriguez, M. A.; Ottensen, R.; LaCasce, A. S.; Nademanee, A. P.; Millenson, M.; Czuczman, M.; Niland, J.; Zelenetz, A. D.; more...
    Blood (2003)

    Fulltext@MSK | Save